Search Results 61-70 of 16093 for pharmacogenetics

  1. Matthew P. Goetz, M.D. - Doctors and Medical Staff - Mayo Clinic

    2023 - 2024. Chair2024 Scientific Program Subcommittee, Pharmacology, Pharmacogenetics and Pharmacogenomics Subcommittee, Experimental and Molecular ...

  2. Comparison of Pharmacogenomic Testing Results Across Companies - Mayo Clinic

    The purpose of this study is to: To evaluate whether the genotypic and phenotypic results for a single subject are the same among companies offering ...

  3. Return of Results of Pharmacogenomic Testing for Genes Involved in Metabolism of 5FU and Capecitibine - Mayo Clinic

    About this study. A group of Mayo Clinic Biobank participants were genotyped for genetic variants as part of a separate study and a subset were found to be ...

  4. Pharmacogenomics and the Potential for Utilization of Testing Results for Patient Care in the Cardiac Surgical Intensive Care Unit - Mayo Clinic

    About this study. The overall goals of this pilot study are to: (1) describe pharmacogenomics (PGx) testing results and identify PGx variants that may ...

  5. Victor E. Ortega, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    ... pharmacogenetics). His research champions ethnic and racial diversity to improve inclusion in genetic studies focused on understanding health disparities ...

  6. Understanding Test Results - Center for Individualized Medicine - Mayo Clinic Research

    Read frequently asked questions and answers about genetic testing and genetic testing results from the Mayo Clinic Center for Individualized Medicine.

  7. Janet E. Olson, Ph.D. - Mayo Clinic Faculty Profiles

    This study recently used pharmacogenetic (PGx) data on 11,000 subjects within the Mayo Clinic Biobank as part of the Right Drug, Right Dose, Right Time ...

  8. Faculty and Staff - Pharmacogenomics - Mayo Clinic Research

    Faculty and staff of the Pharmacogenomics Lab of Richard Weinshilboum, M.D., at Mayo Clinic's campus in Rochester, Minnesota.

  9. Clinical Trials - 2020 Archives

    Largest pharmacogenetic clinical trial in cardiology shows potential benefit in individualized approach to anti-platelet therapy. Terri Malloy. August 25 ...

  10. A Study to Evaluate Patient Experiences with Pharmacogenomic-Based Individualized Medicine - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...